Ken Griffin's position in Pieris Pharmaceuticals is currently worth $21.8. That's 0.00% of their equity portfolio (5139th largest holding). The first Pieris Pharmaceuticals trade was made in Q4 2017. Since then Ken Griffin bought shares 26 more times and sold shares on twenty occasions. The investor's estimated purchase price is $177, resulting in a loss of 88%.